Aligos Therapeuticsinc Stock Probability of Future Stock Price Finishing Over 0.8
| ALGS Stock | USD 0.80 0.05 6.67% |
Closest to current price Aligos long PUT Option Payoff at Expiration
Aligos |
Aligos TherapeuticsInc Target Price Odds to finish over 0.8
The tendency of Aligos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.80 | 90 days | 0.80 | about 61.25 |
Based on a normal probability distribution, the odds of Aligos TherapeuticsInc to move above the current price in 90 days from now is about 61.25 (This Aligos TherapeuticsInc probability density function shows the probability of Aligos Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.29 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aligos TherapeuticsInc will likely underperform. Additionally Aligos TherapeuticsInc has an alpha of 0.1848, implying that it can generate a 0.18 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Aligos TherapeuticsInc Price Density |
| Price |
Predictive Modules for Aligos TherapeuticsInc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aligos TherapeuticsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aligos TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aligos TherapeuticsInc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aligos TherapeuticsInc is not an exception. The market had few large corrections towards the Aligos TherapeuticsInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aligos TherapeuticsInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aligos TherapeuticsInc within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.18 | |
β | Beta against NYSE Composite | 2.29 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | 0.05 |
Aligos TherapeuticsInc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aligos TherapeuticsInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aligos TherapeuticsInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aligos TherapeuticsInc had very high historical volatility over the last 90 days | |
| Aligos TherapeuticsInc has some characteristics of a very speculative penny stock | |
| Aligos TherapeuticsInc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 15.53 M. Net Loss for the year was (87.68 M) with loss before overhead, payroll, taxes, and interest of (71.17 M). | |
| Aligos TherapeuticsInc currently holds about 159.34 M in cash with (79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Vanguard Group Inc. Increases Stock Position in Aligos Therapeutics, Inc. - Defense World |
Aligos TherapeuticsInc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aligos Stock often depends not only on the future outlook of the current and potential Aligos TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aligos TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.3 M | |
| Cash And Short Term Investments | 135.8 M |
Aligos TherapeuticsInc Technical Analysis
Aligos TherapeuticsInc's future price can be derived by breaking down and analyzing its technical indicators over time. Aligos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aligos TherapeuticsInc. In general, you should focus on analyzing Aligos Stock price patterns and their correlations with different microeconomic environments and drivers.
Aligos TherapeuticsInc Predictive Forecast Models
Aligos TherapeuticsInc's time-series forecasting models is one of many Aligos TherapeuticsInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aligos TherapeuticsInc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Aligos TherapeuticsInc
Checking the ongoing alerts about Aligos TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aligos TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aligos TherapeuticsInc had very high historical volatility over the last 90 days | |
| Aligos TherapeuticsInc has some characteristics of a very speculative penny stock | |
| Aligos TherapeuticsInc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 15.53 M. Net Loss for the year was (87.68 M) with loss before overhead, payroll, taxes, and interest of (71.17 M). | |
| Aligos TherapeuticsInc currently holds about 159.34 M in cash with (79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Vanguard Group Inc. Increases Stock Position in Aligos Therapeutics, Inc. - Defense World |
Check out Aligos TherapeuticsInc Backtesting, Aligos TherapeuticsInc Valuation, Aligos TherapeuticsInc Correlation, Aligos TherapeuticsInc Hype Analysis, Aligos TherapeuticsInc Volatility, Aligos TherapeuticsInc History as well as Aligos TherapeuticsInc Performance. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.